Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

被引:979
作者
Arvanitakis, Z
Wilson, RS
Bienias, JL
Evans, DA
Bennett, DA
机构
[1] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Armour Acad Ctr, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[3] Rush Univ, Med Ctr, Dept Psychol, Chicago, IL 60612 USA
[4] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA
[5] Rush Univ, Med Ctr, Rush Inst Healthy Aging, Chicago, IL 60612 USA
关键词
D O I
10.1001/archneur.61.5.661
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Few prospective studies have assessed diabetes mellitus as a risk factor for incident Alzheimer disease (AD) and decline in cognitive function. Objective: To evaluate the association of diabetes mellitus with risk of AD and change in different cognitive systems. Design: Longitudinal cohort study. Participants: For up to 9 years, 824 older (those >55 years) Catholic nuns, priests, and brothers underwent detailed annual clinical evaluations. Main Outcome Measures: Clinically diagnosed AD and change in global and specific measures of cognitive function. Results: Diabetes mellitus was present in 127 (15.4%) of the participants. During a mean of 5.5 years of observation, 151 persons developed AD. In a proportional hazards model adjusted for age, sex, and educational level, those with diabetes mellitus had a 65% increase in the risk of developing AD compared with those without diabetes mellitus (hazard ratio, 1.65; 95% confidence interval, 1.10-2.47). In random effects models, diabetes mellitus was associated with lower levels of global cognition, episodic memory, semantic memory, working memory, and visuospatial ability at baseline. Diabetes mellitus was associated with a 44% greater rate of decline in perceptual speed (P=.02), but not in other cognitive systems. Conclusions: Diabetes mellitus may be associated with an increased risk of developing AD and may affect cognitive systems differentially.
引用
收藏
页码:661 / 666
页数:6
相关论文
共 40 条
[1]
Natural history of mild cognitive impairment in older persons [J].
Bennett, DA ;
Wilson, RS ;
Schneider, JA ;
Evans, DA ;
Beckett, LA ;
Aggarwal, NT ;
Barnes, LL ;
Fox, JH ;
Bach, J .
NEUROLOGY, 2002, 59 (02) :198-205
[2]
Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer's disease [J].
Bennett, DA ;
Wilson, RS ;
Schneider, JA ;
Evans, DA ;
Aggarwal, NT ;
Arnold, SE ;
Cochran, EJ ;
Berry-Kravis, E ;
Bienias, JL .
NEUROLOGY, 2003, 60 (02) :246-252
[3]
Evidence for genetic linkage of Alzheimer's disease to chromosome 10q [J].
Bertram, L ;
Blacker, D ;
Mullin, K ;
Keeney, D ;
Jones, J ;
Basu, S ;
Yhu, S ;
McInnis, MG ;
Go, RCP ;
Vekrellis, K ;
Selkoe, DJ ;
Saunders, AJ ;
Tanzi, RE .
SCIENCE, 2000, 290 (5500) :2302-+
[4]
Ageing and diabetes: implications for brain function [J].
Biessels, GJ ;
van der Heide, LP ;
Kamal, A ;
Bleys, RLAW ;
Gispen, WH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 441 (1-2) :1-14
[5]
Boyt AA, 2000, NEUROSCIENCE, V95, P727
[6]
Purified recombinant insulin-degrading enzyme degrades amyloid β-protein but does not promote its oligomerization [J].
Chesneau, V ;
Vekrellis, K ;
Rosner, MR ;
Selkoe, DJ .
BIOCHEMICAL JOURNAL, 2000, 351 :509-516
[7]
COX DR, 1972, J R STAT SOC B, V34, P187
[8]
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose [J].
Craft, S ;
Asthana, S ;
Newcomer, JW ;
Wilkinson, CW ;
Matos, IT ;
Baker, LD ;
Cherrier, M ;
Lofgreen, C ;
Latendresse, S ;
Petrova, A ;
Plymate, S ;
Raskind, M ;
Grimwood, K ;
Veith, RC .
ARCHIVES OF GENERAL PSYCHIATRY, 1999, 56 (12) :1135-1140
[9]
Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease - Relationship to severity of dementia and apolipoprotein E genotype [J].
Craft, S ;
Peskind, E ;
Schwartz, MW ;
Schellenberg, GD ;
Raskind, M ;
Porte, D .
NEUROLOGY, 1998, 50 (01) :164-168
[10]
DIABETES AND COGNITIVE IMPAIRMENT - A COMMUNITY-BASED STUDY OF ELDERLY SUBJECTS [J].
CROXSON, SCM ;
JAGGER, C .
AGE AND AGEING, 1995, 24 (05) :421-424